Indian vaccine gets FDA emergency use authorization
MANILA, Philippines — India’s Bharat Biotech may now ship its vaccines against COVID-19 to the country as it has secured a full emergency use authorization (EUA) from the Food and Drug Administration (FDA).
Eric Domingo, FDA director general, said the full EUA was given to Bharat Biotech’s Covaxin after it submitted a good manufacturing practice certificate as required by the FDA.
Domingo explained that without this certificate, it would be unable to bring the vaccine into the county.
“But they submitted it last week, so now they could import and use [the vaccine] in the country,” Domingo said at an online briefing.
The private sector had ordered 8 million doses of Bharat’s Covaxin. —Leila B. Salaverria
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.